We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Demonstrates Human-Centered Engineering and Automation for Laboratory Testing

By LabMedica International staff writers
Posted on 30 Jul 2024
Print article
Image: Siemens is presenting the latest innovations and trends in clinical diagnostics at ADLM 2024 (Photo courtesy of Siemens Healthineers)
Image: Siemens is presenting the latest innovations and trends in clinical diagnostics at ADLM 2024 (Photo courtesy of Siemens Healthineers)

At the ADLM 2024 Clinical Lab Expo, Siemens Healthineers (Forchheim, Germany) is demonstrating what’s achievable for laboratory testing with human-centered engineering and automation. The company’s new capabilities bring unmatched automation to laboratories of all sizes. Enhancements to the Atellica Portfolio underscore sustainability, leading workflow efficiency, AI-enabled intelligence, and advanced analytics to turn data into practical clinical insights.

Clinical laboratories face universal challenges to operate more efficiently, process more samples, run more reports, or get more productivity from less staff. This friction detracts from the value laboratory staff can contribute to clinicians and patients. Successful automation addresses the specific needs of each lab while standardizing tasks that safeguard quality and safety. Siemens consolidates 25 tasks directly into the Atellica systems, which are on display at ADLM 2024. Chip, sensors, and lines of code work together to help simplify tasks and minimize hands-on time. In minutes, a single technologist can manage calibration and QC, daily sorting, and archiving processes—tasks that historically may have taken hours—to improve throughput and reduce waste. Atellica Integrated Automation, for example, can reduce end-to-end manual workflow steps by 75% and 65% of samples run on Atellica Sample Handler can see faster turnaround times than competitor systems

Attendees to the meeting can also see how the Atellica Portfolio is supporting wider health system efficiencies. The ability to shift employees from location to location is increasingly important to maintain the required staffing to keep laboratories operational. The industry-leading modular and connectivity options offered by Siemens seamlessly integrate advanced automation into small and mega-labs alike. The Atellica Solution and Atellica CI Analyzer offer a consistent user experience so that entry-level professionals and experienced medical technologists can be ready to process samples anywhere in the network. Health systems also benefit from the analyzers’ cost savings and sustainability—they consume the least water compared to other integrated analytical systems and 98.3% of Atellica Solution materials can be recycled.

Additionally, Siemens is introducing visitors to its booth to FlexLab X, the next-generation total lab automation solution by Inpeco. This next-generation automation system aims to redefine automation excellence by offering enhanced flexibility, ease of use, and efficiency. Siemens offers several decentralized testing solutions that enable timely decision-making and treatment. Informatics, emergency, and critical care solutions such as the epoc Blood Analysis System are available for demonstration. Throughout the show, clinical experts from Siemens are presenting more than 30 scientific posters. Research topics include automation and analytical techniques, cardiac markers, clinical and diagnostic immunology, endocrinology and metabolism, pediatric and maternal-fetal medicine, therapeutic drug monitoring and toxicology, and tumor markers and cancer diagnostics.

"Test results are the red thread that informs care decisions. Patients rely on laboratory scientists’ expertise for fast and reliable results and insights. Standing in the way are burdensome, repetitive manual tasks that take significant time but are critical and that’s where our new automation features play an essential role,” said Sharon Bracken, head of Diagnostics for Siemens Healthineers. “Knowing where to start with automation can be overwhelming, so our goal with human-centered engineering is to simplify, allowing the labs we serve to focus on advancing patient care.”

Related Links:
Siemens Healthineers

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.